Clinical question
How well is opioid agonist therapy (OAT) managed in primary care?
Bottom line
For patients dependent on opioids, receiving OAT in a primary care setting versus a specialized opioid treatment program resulted in an additional 1 in 6 patients retained in treatment and abstinent from street opioids at 42 weeks. Additionally, almost twice as many patients (77% vs 38%) reported being very satisfied with their care. All studies had supports and training available to their primary care teams.
Evidence
Three RCTs (46 to 221 patients)1–3 compared OAT (methadone or buprenorphine) in primary care versus a specialized opioid treatment program; mean follow-up was 42 weeks.
Retention in treatment (3 RCTs of 287 patients; meta-analysis done by Tools for Practice authors) was 86% versus 67% in specialty care (number needed to treat of 6).
Street opioid abstinence (3 RCTs of 313 patients; measured by urine toxicology or self-report; meta-analysis done by Tools for Practice authors) was 53% versus 35% in specialty care (number needed to treat of 6).
Patient satisfaction was high:
Withdrawal symptoms were statistically significantly reduced from baseline, but there was no difference between groups (1 RCT of 46 patients).3
Adverse events were not reported.
Context
The study populations varied1–3:
In 1 RCT, patients had been receiving methadone for 1 year or more and were abstinent from street drugs at randomization1; in another, patients were not taking methadone or were switching from buprenorphine2; and in the third RCT, patients were on a methadone waiting list and had urine screening results positive for opioids.3
Supportive teams and training were used in the RCTs1–3:
One primary care clinic was affiliated with a substance misuse clinic.3
One study enrolled only physicians with experience in treating opioid or other drug dependence.2
One study provided physicians with training and 24-hour pager support.1
More than 50% of surveyed physicians reported inadequate staff support and training, time, and office space as barriers to prescribing OAT in their practices.4,5
Implementation
Primary care practitioners can treat opioid use disorder and they do it well. Primary care teams and clinician support and training can facilitate improved outcomes.1–3 Other specialist supports for primary care practitioners treating opioid use disorder are increasing across Canada through consultation and pain and addiction mentorship programs.6–8 Other educational resources include online training.9–11 In addition, practical patient handouts on topics such as home- or office-based induction of buprenorphine are available to assist practitioners.12
Notes
Tools for Practice articles in Canadian Family Physician are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in Canadian Family Physician are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.
Footnotes
Competing interests
None declared
The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.
- Copyright© the College of Family Physicians of Canada